VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Kiadis Pharma

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 25 out of 100

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Kiadis Pharma B.V. is focused on cell-based immunotherapy products for the treatment of life threatening diseases. Kiadis is focused on developing new cancer immunotherapeutics as well as novel adjunctive treatments for patients undergoing hematopoietic stem cell transplants. The company’s lead product, K-NKoo2, is in a phase 2 study evaluating haplo-identical NK cells to prevent post-transplant relapse in AML and MDS.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy